HFA Premium Access

The rates of use of drugs that reduce mortality in patients with reduced ejection fraction in turkish population

Presentation

About the speaker

Associate Professor Tarik Kivrak

Firat University, Elazig (Turkey)
0 follower

25 more presentations in this session

Safety and tolerability of a first in class chymase inhibitor in clinically stable patients with left-ventricular dysfunction after myocardial infarction

Speaker: Doctor M. Senni (Bergamo, IT)

Thumbnail

The relations between pro- and anti-inflammatory cytokines contractile ability of the myocardium in patients with coronary artery disease

Thumbnail

Predictors of galectin-3 in patients with heart failure and reduced ejection fraction

Speaker: Doctor I. Alexanian (Athens, GR)

Thumbnail

The role of Response-to-Diuretic in predicting prognosis in discharged heart failure patients after an acute decompensation.

Speaker: Doctor M. Feola (Mondovi, IT)

Thumbnail

Mobile cardiopaging in toxic cardiomyopathy diagnostics in cancer patients

Speaker: Professor N. Lyamina (Moscow, RU)

Thumbnail

Access the full session

Poster Session 4 - Chronic Heart Failure – Pathophysiology and Mechanisms

Speakers: Associate Professor T. Kivrak, Doctor M. Senni, Doctor I. Alexanian, Doctor M. Feola, Professor N. Lyamina
Thumbnail

About the event

Image

Heart Failure 2018 & World Congress on Acute Heart Failure

26 May - 29 May 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk